Home › Pagkabigo ng Puso › Wisconsin › Milwaukee
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Milwaukee, WI
16 pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Milwaukee (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Nagre-recruitPhase 3
- Medical College of Wisconsin / Froedtert Hospital, Milwaukee
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Nagre-recruitPhase 3
- ProHealth Care Research Institute and Cardiology Associates, Waukesha · 17 mi ang layo
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Nagre-recruitPhase 3
- Advocate Aurora Saint Lukes Medical Center, Milwaukee
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Nagre-recruitPhase 3
- Milwaukee, WI Investigative Site 10061, Milwaukee
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Nagre-recruit
- Aurora St. Luke's Medical Center, Milwaukee
Peripheral Venous Pressure (PVP) Trial
Nagre-recruit
- Aurora St. Luke's Medical Center, Milwaukee
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Nagre-recruitPhase 2
- Froedtert Hospital - Center for Advanced Care, Milwaukee
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Nagre-recruitObservasyonal na pag-aaral
- Milwaukee, Milwaukee
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Nagre-recruitObservasyonal na pag-aaral
- Medical College of Wisconsin, Inc (PI Address), Milwaukee
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- Aurora St. Luke's Medi Ctr, Milwaukee
ELEVATE-HFpEF Clinical Study
Nagre-recruit
- Froedtert Hospital, Milwaukee
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Nagre-recruitPhase 3
- Milwaukee, WI Investigative Site FIN-10428, Milwaukee
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Nagre-recruit
- Advocate Aurora St. Luke's, Milwaukee
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Nagre-recruit
- Aurora Medical Group, Milwaukee
CCM OPEN HF Registry
Nagre-recruitObservasyonal na pag-aaral
- Advocate Aurora Health-St. Lukes, Milwaukee
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Nagre-recruit
- Advocate Aurora Research Institute, Milwaukee
Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod
- New York City, NY50 pag-aaral
- Boston, MA43 pag-aaral
- Dallas, TX42 pag-aaral
- Houston, TX36 pag-aaral
- Cleveland, OH33 pag-aaral
- Chicago, IL32 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- St. Louis, MO26 pag-aaral
- Durham, NC26 pag-aaral
- Kansas City, MO25 pag-aaral
- Atlanta, GA25 pag-aaral
Iba pang pag-aaral sa Milwaukee
- Kanser (lahat ng uri)23 pag-aaral
- Kanser sa Suso23 pag-aaral
- Non-Small Cell Lung Cancer22 pag-aaral
- Multiple Myeloma21 pag-aaral
- Kanser sa Baga21 pag-aaral
- Kanser sa Prostate20 pag-aaral
- Follicular Lymphoma19 pag-aaral
- Kanser sa Pancreas18 pag-aaral
- Non-Hodgkin Lymphoma18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Burkitt Lymphoma16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.